Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia.
Albasanz-Puig A, Durà-Miralles X, Laporte-Amargós J, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo JM, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Retamar-Gentil P, Aguado JM, Montero M, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmati P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Pallarès N, Bergas A, Carratalà J, Gudiol C, On Behalf Of The Ironic Study Group. Albasanz-Puig A, et al. Among authors: mussetti a. Microorganisms. 2022 Mar 29;10(4):733. doi: 10.3390/microorganisms10040733. Microorganisms. 2022. PMID: 35456784 Free PMC article.
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Gudiol C, Albasanz-Puig A, Laporte-Amargós J, Pallarès N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Paz Morales H, Brunel AS, García E, Isler B, Kern WV, Morales I, Maestro-de la Calle G, Montero M, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatti P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J; IRONIC Study Group. Gudiol C, et al. Among authors: mussetti a. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02494-19. doi: 10.1128/AAC.02494-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32015035 Free PMC article.
Handling the COVID-19 pandemic in the oncological setting.
Mussetti A, Maluquer C, Albasanz-Puig A, Gudiol C, Moreno-Gonzalez G, Corradini P, Sureda A. Mussetti A, et al. Lancet Haematol. 2020 May;7(5):e365-e366. doi: 10.1016/S2352-3026(20)30108-3. Epub 2020 Apr 1. Lancet Haematol. 2020. PMID: 32246913 Free PMC article. No abstract available.
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G, Mussetti A, Albasanz-Puig A, Salvador I, Sureda A, Gudiol C, Salazar R, Marin M, Garcia M, Navarro V, de la Haba Vaca I, Coma E, Sanz-Linares G, Dura X, Fontanals S, Serrano G, Cruz C, Mañez R. Moreno-González G, et al. Among authors: mussetti a. Trials. 2021 Feb 5;22(1):116. doi: 10.1186/s13063-021-05072-4. Trials. 2021. PMID: 33546739 Free PMC article.
Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience.
Salas MQ, Mussetti A, Muñóz C, Albasanz-Puig A, Patiño B, Jimenez Prat L, Gudiol C, Parody R, Sureda A. Salas MQ, et al. Among authors: mussetti a. Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):440-443. doi: 10.1016/j.htct.2021.01.002. Epub 2021 Feb 8. Hematol Transfus Cell Ther. 2022. PMID: 33583766 Free PMC article. No abstract available.
The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting.
Condom M, Mussetti A, Maluquer C, Parody R, González-Barca E, Arnan M, Albasanz-Puig A, Pomares H, Salas MQ, Carro I, Peña M, Clapes V, Baca Cano C, Oliveira Ramos AC, Sanz-Linares G, Moreno-González G, Mercadal S, Boqué C, Gudiol C, Domingo-Domènech E, Sureda A. Condom M, et al. Among authors: mussetti a. Cancer Rep (Hoboken). 2021 Aug;4(4):e1358. doi: 10.1002/cnr2.1358. Epub 2021 Mar 3. Cancer Rep (Hoboken). 2021. PMID: 33656801 Free PMC article.
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.
Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailen R, Barba P, Benzaquén A, Briones J, Caballero AC, Campos A, Español I, Ferra C, López SG, González Sierra PA, Guerra LM, Hernani R, Iacoboni G, Jiménez-Ubieto A, Kwon M, Corral LL, López-Godino O, Munoz MCM, Martínez-Cibrián N, Gómez JM, Pérez-Ortega L, Ortí G, Ortiz-Maldonado V, Pascual MJ, Perera M, Perez A, Reguera JL, Sanchez JM, Sanz J, Torrent A, Yáñez L, Varela R, Echechipia IC, Caballero D, Sureda A. Mussetti A, et al. Bone Marrow Transplant. 2023 Jun;58(6):738. doi: 10.1038/s41409-023-01967-9. Bone Marrow Transplant. 2023. PMID: 37076611 No abstract available.
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.
Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailen R, Barba P, Benzaquén A, Briones J, Caballero AC, Campos A, Español I, Ferra C, López SG, González Sierra PA, Guerra LM, Hernani R, Iacoboni G, Jiménez-Ubieto A, Kwon M, Corral LL, López-Godino O, Munoz MCM, Martínez-Cibrián N, Gómez JM, Pérez-Ortega L, Ortí G, Ortiz-Maldonado V, Pascual MJ, Perera M, Perez A, Reguera JL, Sanchez JM, Sanz J, Torrent A, Yáñez L, Varela R, Echechipia IC, Caballero D, Sureda A. Mussetti A, et al. Bone Marrow Transplant. 2023 Jun;58(6):673-679. doi: 10.1038/s41409-023-01949-x. Epub 2023 Mar 14. Bone Marrow Transplant. 2023. PMID: 36918682
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation.
Montefusco V, Spina F, Patriarca F, Offidani M, Bruno B, Montanari M, Mussetti A, Sperotto A, Scortechini I, Dodero A, Fanin R, Valagussa P, Corradini P. Montefusco V, et al. Among authors: mussetti a. Biol Blood Marrow Transplant. 2013 Mar;19(3):424-8. doi: 10.1016/j.bbmt.2012.10.032. Epub 2012 Nov 8. Biol Blood Marrow Transplant. 2013. PMID: 23142330 Free article. Clinical Trial.
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide.
Montefusco V, Galli M, Spina F, Stefanoni P, Mussetti A, Perrone G, De Philippis C, Dalto S, Maura F, Bonini C, Rezzonico F, Pennisi M, Roncari L, Soldarini M, Dodero A, Farina L, Cocito F, Caprioli C, Corradini P. Montefusco V, et al. Among authors: mussetti a. Leuk Lymphoma. 2014 Sep;55(9):2032-7. doi: 10.3109/10428194.2014.914203. Epub 2014 Jun 5. Leuk Lymphoma. 2014. PMID: 24730540
91 results